Common questions about Gliclazide Servier (FAQ)
Q: How quickly does Gliclazide Servier start working after the first dose?
Official pharmacokinetic data describes how the medicine acts in the body. Plasma levels of the active ingredient increase steadily over approximately six hours. The concentration then remains at a consistent level, or a plateau, that is maintained until about twelve hours after the tablet is administered.
Q: Does Gliclazide Servier cause weight gain?
According to official patient information, weight gain has been reported as a possible adverse effect that may occur while using this medication. Not everyone who takes the medicine will experience this effect.
Q: What are the signs of low blood sugar (hypoglycaemia) when taking this drug?
Low blood sugar (hypoglycaemia) is a common side effect of this medicine. Symptoms described in official regulatory documents may include feeling shaky, sweating, tremor, or intense hunger. Other signs can involve reduced concentration, confusion, dizziness, and changes in heart rate such such as a rapid or irregular beat.
Q: Can Gliclazide Servier cause dizziness or lightheadedness?
Official product information states that dizziness can be a symptom associated with an episode of low blood sugar, or hypoglycemia. Since low blood sugar is a common effect of this medicine, dizziness is reported indirectly through this known side effect.
Q: What happens if Gliclazide Servier is taken when blood sugar is already low?
Regulatory safety information indicates that the risk of severe hypoglycemia is increased if the drug is taken when the body's energy intake is deficient, or during heavy or severe exercise. Severe low blood sugar can impair concentration and reaction.
Q: Is Gliclazide Servier commonly prescribed alongside Metformin?
Regulatory documents state that this medicine may be used as part of a combination therapy to treat high blood sugar. This includes use alongside other medicines, such as Metformin.
Q: Does Gliclazide Servier affect driving ability or machine operation?
The official product information advises that the ability to concentrate and react may be impaired if blood sugar levels are too low (hypoglycemia) or too high (hyperglycemia). Official regulatory documents specify that professional guidance is necessary for individuals with frequent episodes of low blood sugar regarding driving safety.
Q: Is Gliclazide Servier a permanent medication for diabetes?
Official guidance describes the treatment for Type 2 diabetes as often lifelong. The medication is therefore described as part of a long-term management plan that should only be altered under the specific direction of a healthcare professional.
Q: What non-drug products or foods should be avoided while using Gliclazide Servier?
Regulatory documents describe the known interactions with certain non-drug substances. The consumption of alcohol is generally not recommended as it potentiates the hypoglycaemic reaction. Co-administration of the herbal product St. John's Wort is also listed in official information as requiring caution.
Q: Is Gliclazide Servier used in any countries outside of Europe?
Yes, this medication is approved and used in multiple international jurisdictions. Official regulatory information, including documents from Australia (TGA) and Health Canada, indicates that the medication is available and referenced in numerous countries outside of Europe.
Q: What is the difference in how Gliclazide Servier works compared to insulin?
The mechanism of Gliclazide works by stimulating the body’s own pancreatic cells to release more of its stored insulin (an action known as an insulin secretagogue). This is different from exogenous (external) insulin, which is administered directly into the body from an outside source.
Q: Why is the 'Servier' brand name included when the drug name is Gliclazide?
Servier is the name of the originator company that developed the modified-release formulation of this medicine. Regulatory documentation and trade names (like 'Diamicron MR') often include the originator or brand name for clear product identification.
Q: Can Gliclazide Servier affect a person's mood?
Official product information states that signs of low blood sugar, a common side effect, may include mood-related changes. These can involve restlessness, aggressiveness, reduced alertness, and depression.
Q: What are the official guidelines regarding stopping Gliclazide Servier?
Official product guidance describes the medication as part of long-term therapy. Regulatory documents specify that any decision to stop or alter medication use must be made under the specific direction of a prescribing healthcare professional.
Q: Can a person take Gliclazide Servier if they have a sulfa allergy?
Official prescribing information generally states that the medicine is contraindicated if a person has ever had an allergic reaction to gliclazide, other sulfonylureas, or sulfonamide (sulfur) antibiotics. This is due to the chemical relationship between the drug class and sulfonamides.
Q: Why do doctors prescribe Gliclazide Servier instead of just focusing on diet and exercise?
Official documents indicate that this medication is prescribed for adults with Type 2 diabetes when initial management through diet, exercise, and weight loss alone has not been sufficient to maintain adequate blood sugar control. It is used to help achieve the necessary level of glycemic management.
Q: Does Gliclazide Servier lose its effectiveness over time?
Official warnings and precautions acknowledge that the blood glucose lowering effect of any oral antidiabetic agent, including Gliclazide, may lessen over time in some patients. This is often attributed to the natural progression of the severity of the diabetes.
